5Transparency International Global Corruption Report[R].London,Pluto Press,2006.
6WHO Medicines Strategy 2004-2007:countries at the core[R].Geneva,World Health Organization,2004.
7Cohen JC,Mrazek MF,Hawkins L.Corruption and Pharmaceuticals:Strengthening Good Governance to Improve Access.In Campos J,Pradhan S.ed.The Many Faces of Corruption:Tracking Vulnerabilities at the Sector Level,(pp.29-62).Washington,D.C.The World Bank,2007.
8MeTA.Towards A Medicines Transparency Alliance[EB/OL].http://www.dfidhealthrc.org/Me TA/february_meeting.html,2010-02-25.
9Jillian Clare Cohen.Pharmaceuticals and corruption:a risk assess-ment[R].In Global Corruption Report 2006.London:Transparency International; 2006:77-84.
10MeTA.Transparency and Accountability in the Supply of Medicines[EB/OL].http://www.dfidhealthrc.org/MeTA/february_meeting.html,2010-02-25.
